Discovery of Bis-sulfonamides as Novel Inhibitors of Mitochondrial NADH-Quinone Oxidoreductase (Complex I)

Atsuhito Tsuji; Takahiro Masuya; Norihito Arichi; Shinsuke Inuki; Masatoshi Murai; Hideto Miyoshi; Hiroaki Ohno

doi:10.1021/acsmedchemlett.2c00504

Discovery of Bis-sulfonamides as Novel Inhibitors of Mitochondrial NADH-Quinone Oxidoreductase (Complex I)

ACS Med Chem Lett. 2023 Jan 24;14(2):211-216. doi: 10.1021/acsmedchemlett.2c00504. eCollection 2023 Feb 9.

Authors

Atsuhito Tsuji¹, Takahiro Masuya², Norihito Arichi¹, Shinsuke Inuki¹, Masatoshi Murai², Hideto Miyoshi², Hiroaki Ohno¹

Affiliations

¹ Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
² Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan.

Abstract

Mitochondrial oxidative phosphorylation (OXPHOS) is an essential cellular metabolic process that generates ATP. The enzymes involved in OXPHOS are considered to be promising druggable targets. Through screening of an in-house synthetic library with bovine heart submitochondrial particles, we identified a unique symmetric bis-sulfonamide, KPYC01112 (1) as an inhibitor targeting NADH-quinone oxidoreductase (complex I). Structural modifications of KPYC01112 (1) led to the discovery of the more potent inhibitors 32 and 35 possessing long alkyl chains (IC₅₀ = 0.017 and 0.014 μM, respectively). A photoaffinity labeling experiment using a newly synthesized photoreactive bis-sulfonamide ([¹²⁵I]-43) revealed that it binds to the 49-kDa, PSST, and ND1 subunits which make up the quinone-accessing cavity of complex I.